Skip to main content

Table 3 Cox regression analysis of SRD5A3 and other clinicopathological factors in BC patients

From: Over-expression of SRD5A3 and its prognostic significance in breast cancer

Covariates Univariate analysis Multivariate analysis
HR 95% CI P-value HR 95% CI P-value
Age 1.018 1.005–1.030 0.004 1.039 1.020–1.059 < 0.001
Gender female 0.429 0.136–1.349 0.148 1.137 0.258–5.010 0.866
Stage 2 NA NA NA 1.268 0.000–4.583E+ 43 0.996
Stage 3 68.847 17.534–270.327 < 0.001 211,065.668 0.000–1.280E+ 43 0.782
Stage 4 823,685.985 0.000–2.511E+ 72 0.862 184,003.037 0.000–1.125E+ 43 0.785
HER2 + 0.468 0.115–1.907 0.289 0.264 0.063 1.101 0.068
Triple-negative 0.327 0.132–0.810 0.016 0.545 0.217 1.366 0.195
SRD5A3 1.000 1.000–1.000 0.014 1.865 1.129 3.081 0.015
  1. 95% CI 95% confidential interval